APP and Alzheimer disease: In fact, the study of AD mouse model APP/PS1 brains using FTIR microscopy has demonstrated the presence of non-fibrillar aggregates in situ, which is compatible with the FTIR spectra of oligomers and aggregates formed at low pH in the early stages of the disease (3–6 months).